Yesterday I learned of another company that is remaking itself. BiOptix Diagnostics (BIOP) is now Riot Blockchain (RIOT). Its new focus is blockchain and cryptocurrency.
Heretofore it was known for its development of proprietary (ESPR) enhanced surface plasmon resonance platforms for molecular detection (which is related to nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications), which probably leveraged the work of Dr John Hall, Physicist and Nobel laureate. It will license its legacy biotech assets, and dive directly into the blockchain and cryptocurrency realms. RIOT's first big step is the purchase of Canadian-based TESS, Inc., which has expertise in building guaranteed payment systems for wholesale telecommunication carriers (e.g., “smart contracts”). Their second step was announced in November: they will mine cryptocurencies. In short, I bought using the same rationale that I used for OSTK.